TY  - JOUR

T1  - TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML

JO  - Blood Advances

UR  - https://doi.org/10.1182/bloodadvances.2020002512

PY  - 2020/10/15

AU  - Vadakekolathu J

AU  - Lai C

AU  - Reeder S

AU  - Church SE

AU  - Hood T

AU  - Lourdusamy A

AU  - Rettig MP

AU  - Aldoss I

AU  - Advani AS

AU  - Godwin J

AU  - Wieduwilt MJ et al

ED  - 

DO  - DOI: 10.1182/bloodadvances.2020002512

PB  - American Society of Hematology

VL  - 4

IS  - 20

SP  - 5011

EP  - 5024

Y2  - 2026/02/25

ER  -